The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University BPC 157: Miracle Healing Peptide or Hidden Danger? Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law